The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
In-depth immune and molecular profiling of melanoma patients receiving adoptive T-cell therapy reveals biomarkers of efficacy in ATATIL study.
 
Angela Orcurto
No Relationships to Disclose
 
Johanna Chiffelle
No Relationships to Disclose
 
Eleonora Ghisoni
No Relationships to Disclose
 
David Barras
No Relationships to Disclose
 
Isaac Crespo
No Relationships to Disclose
 
Blanca Navarro Rodrigo
No Relationships to Disclose
 
María Ochoa de Olza
Honoraria - MSD (Inst)
 
Martina Imbimbo
No Relationships to Disclose
 
Sylvie Rusakiewicz
No Relationships to Disclose
 
Stephanie Tissot
No Relationships to Disclose
 
Philippe O Gannon
No Relationships to Disclose
 
Urania Dafni
Honoraria - Roche (Inst)
 
Stefan Zimmermann
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Iovance Biotherapeutics (Inst); MedImmune (Inst); Roche (Inst); T3 Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - AstraZeneca (Inst); MSD (Inst)
 
Lana E. Kandalaft
No Relationships to Disclose
 
Olivier Michielin
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; MSD; Novartis; Roche
Research Funding - Bristol-Myers Squibb; MSD; NeraCare GmbH
Expert Testimony - Bristol-Myers Squibb
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD
 
Michal Bassani-Sternberg
No Relationships to Disclose
 
Denarda Dangaj
No Relationships to Disclose
 
Lionel Trueb
No Relationships to Disclose
 
Alexander Harari
No Relationships to Disclose
 
George Coukos
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Roche/Genentech
Speakers' Bureau - Roche
Research Funding - Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Geneos (Inst); Iovance Biotherapeutics (Inst); Kite, a Gilead company (Inst); NextCure (Inst); Roche (Inst); Sanofi/Aventis (Inst)
Patents, Royalties, Other Intellectual Property - George Coukos has patents in the domain of antibodies and vaccines targeting the tumor vasculature as well as technologies related to T-cell expansion and engineering for T-cell therapy. George Coukos receives royalties from the University of Pennsylvania (Inst)